Nuclear survivin as a biomarker for non-small-cell lung cancer

被引：0
|
作者：
B Lu
A Gonzalez
P P Massion
Y Shyr
B Shaktour
D P Carbone
D E Hallahan
机构：
[1] Vanderbilt Ingram,Department of Radiation Oncology
[2] Cancer Center,Department of Pathology
[3] Vanderbilt University School of Medicine,Department of Medicine
[4] Vanderbilt Ingram,Department of Preventive Medicine
[5] Cancer Center,undefined
[6] Vanderbilt University School of Medicine,undefined
[7] Vanderbilt Ingram,undefined
[8] Cancer Center,undefined
[9] Vanderbilt University School of Medicine,undefined
[10] Vanderbilt Ingram,undefined
[11] Cancer Center,undefined
[12] Vanderbilt University School of Medicine,undefined
来源：
British Journal of Cancer | 2004年 / 91卷
关键词：
survivin; lung cancer; nucleus; tissue array; mitosis; apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Survivin inhibits apoptosis and promotes mitosis. We determined whether nuclear or cytoplasmic localisation of survivin predicts survival of 48 patients with resected non-small-cell lung cancer (NSCLC). Patients with nuclear staining of survivin had significantly worse survival (relative risk: 3.9, P=0.02). Therefore, survivin may be a biomarker for NSCLC.
引用
收藏
页码：537 / 540
页数：3
相关论文
共 50 条
  • [21] IL-33, an Important Biomarker in Non-small-cell Lung Cancer?
    Xie, Qiang
    Wang, Shi-Cun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (12) : 7763 - 7763
  • [22] BIOMARKER-DRIVEN TREATMENT STRATEGIES FOR NON-SMALL-CELL LUNG CANCER
    Okamoto, I.
    ANNALS OF ONCOLOGY, 2012, 23 : 72 - 72
  • [23] Significance of survivin expression in non-small-cell lung cancer(NSCLC): A tissue microarray study
    Tan, DF
    Piao, YC
    Li, Q
    Slocum, HK
    Younis, T
    Wiseman, S
    Brooks, JJ
    Li, FZ
    Ramnath, N
    LABORATORY INVESTIGATION, 2003, 83 (01) : 314A - 314A
  • [24] Significance of survivin expression in non-small-cell lung cancer(NSCLC): A tissue microarray study
    Tan, DF
    Piao, YC
    Li, Q
    Slocum, HK
    Younis, T
    Wiseman, S
    Brooks, JJ
    Li, FZ
    Ramnath, N
    MODERN PATHOLOGY, 2003, 16 (01) : 314A - 314A
  • [25] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Kurata, Takayasu
    Okamoto, Isamu
    Tamura, Kenji
    Fukuoka, Masahiro
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 499 - 504
  • [26] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Takayasu Kurata
    Isamu Okamoto
    Kenji Tamura
    Masahiro Fukuoka
    Investigational New Drugs, 2007, 25 : 499 - 504
  • [27] Advanced Non-Small-Cell Lung Cancer
    Kwon, Hyun W.
    Ham, Soo-Youn
    Shin, Sang W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1997 - +
  • [28] Pembrolizumab in Non-Small-Cell Lung Cancer
    Sorscher, Steven
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 996 - 997
  • [29] Encephalitis in non-small-cell lung cancer
    Costa e Silva, M.
    Silva, E.
    Mendes, A.
    Barroso, A.
    PULMONOLOGY, 2021, 27 (06): : 582 - 583
  • [30] Immunotherapy of non-small-cell lung cancer
    Reinmuth, Niels
    Merk, Martina
    Duell, Thomas
    ONKOLOGE, 2021, 27 (02): : 179 - 190
12345